Form S-3. Notwithstanding the other provisions of this Section 2.1, until the fifth anniversary of the effective date of the Company's first registration statement under the Securities Act, the Company shall be required upon the written request of Holder(s) by this Section 2.1 to effect, and bear all expenses (as determined pursuant to Section 2.1(e) hereof) incurred in connection with, up to two registrations on Form S-3 (or any successor similar form) of Registrable Securities during such period, provided that the Registrable Securities to be registered thereon are expected to have an aggregate disposition price (before deductions for underwriting discounts and commissions) of at least $500,000.
Appears in 9 contracts
Samples: Registration Rights Agreement (Bionumerik Pharmaceuticals Inc), Registration Rights Agreement (Bionumerik Pharmaceuticals Inc), Registration Rights Agreement (Bionumerik Pharmaceuticals Inc)
Form S-3. Notwithstanding the other provisions of this Section 2.1, until commencing on the fifth first anniversary of the effective date Effective Date of the Company's first registration statement under the Securities ActAct until December 31, 2012, the Company shall be required upon the written request of Holder(s) by this Section 2.1 to effect, and bear all expenses (as determined pursuant to Section 2.1(e) hereof) incurred in connection with, up to two registrations on Form S-3 (or any successor similar form) of Registrable Securities during such period, provided that the Registrable Securities to be registered thereon are expected to have an aggregate disposition price (before deductions for underwriting discounts and commissions) of at least $500,0002,000,000.
Appears in 1 contract
Samples: Registration Rights Agreement (BioNumerik Pharmaceuticals, Inc.)